Works matching IS 03407004 AND DT 2022 AND VI 71 AND IP 7

Results: 20

The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1693, doi. 10.1007/s00262-021-03115-y

By:

Wang, Wenxian;
Gu, Xiaodong;
Wang, Liping;
Pu, Xingxiang;
Feng, Huijing;
Xu, Chunwei;
Lou, Guangyuan;
Shao, Lan;
Xu, Yibing;
Wang, Qian;
Wang, Siyuan;
Gao, Wenbin;
Zhang, Yiping;
Song, Zhengbo

Publication type:

Article

Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1787, doi. 10.1007/s00262-022-03145-0

By:

Bellone, Matteo;
Brevi, Arianna;
Bronte, Vincenzo;
Dusi, Silvia;
Ferrucci, Pier Francesco;
Nisticò, Paola;
Rosato, Antonio;
Russo, Vincenzo;
Sica, Antonio;
Toietta, Gabriele;
Colombo, Mario Paolo

Publication type:

Article

Chemical screening identifies novel small molecule activators of natural killer cell cytotoxicity against cancer cells.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1671, doi. 10.1007/s00262-021-03117-w

By:

Lee, Grace;
Karunanithi, Sheela;
Posner, Bruce;
Niederstrasser, Hanspeter;
Cheng, Hong;
Federov, Yuriy;
Manjappa, Shivaprasad;
Musaitif, Karam;
Wang, Huaiyu;
Jackson, Zachary;
Wald, David

Publication type:

Article

Metformin inhibits human non-small cell lung cancer by regulating AMPK–CEBPB–PDL1 signaling pathway.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1733, doi. 10.1007/s00262-021-03116-x

By:

Lu, Tao;
Li, Ming;
Zhao, Mengnan;
Huang, Yiwei;
Bi, Guoshu;
Liang, Jiaqi;
Chen, Zhencong;
Zheng, Yuansheng;
Xi, Junjie;
Lin, Zongwu;
Zhan, Cheng;
Jiang, Wei;
Wang, Qun;
Tan, Lijie

Publication type:

Article

Discontinuation of immune checkpoint inhibitor (ICI) above 18 months of treatment in real-life patients with advanced non-small cell lung cancer (NSCLC): INTEPI, a multicentric retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1719, doi. 10.1007/s00262-021-03114-z

By:

Bilger, Geoffroy;
Girard, Nicolas;
Doubre, Hélène;
Levra, Matteo Giaj;
Giroux-Leprieur, Etienne;
Giraud, Frederique;
Decroisette, Chantal;
Carton, Matthieu;
Massiani, Marie Ange

Publication type:

Article

Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1757, doi. 10.1007/s00262-021-03110-3

By:

Wang, Haolan;
Lu, Liqing;
Liang, Xujun;
Chen, Yongheng

Publication type:

Article

Blood DCs activated with R848 and poly(I:C) induce antigen-specific immune responses against viral and tumor-associated antigens.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1705, doi. 10.1007/s00262-021-03109-w

By:

Hänel, Gerulf;
Angerer, Caroline;
Petry, Katja;
Lichtenegger, Felix S.;
Subklewe, Marion

Publication type:

Article

Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1747, doi. 10.1007/s00262-021-03108-x

By:

Bureau, Mathilde;
Chatellier, Thierry;
Perennec, Tanguy;
Goronflot, Thomas;
Greilsamer, Charlotte;
Chene, Anne-Laure;
Affi, Raafet;
Frampas, Eric;
Bennouna, Jaafar;
Pons-Tostivint, Elvire

Publication type:

Article

Anti-PD1/PDL1 IgG subclass distribution in ten cancer types and anti-PD1 IgG4 as biomarker for the long time survival in NSCLC with anti-PD1 therapy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1681, doi. 10.1007/s00262-021-03106-z

By:

Tan, Qiaoyun;
Dai, Liyuan;
Wang, Yanrong;
Liu, Shuxia;
Liang, Te;
Luo, Rongrong;
Wang, Shasha;
Lou, Ning;
Chen, Haizhu;
Zhou, Yu;
Zhong, Qiaofeng;
Yang, Jianliang;
Xing, Puyuan;
Hu, Xingsheng;
Liu, Yutao;
Zhou, Shengyu;
Yao, Jiarui;
Wu, Di;
Zhang, Zhishang;
Tang, Le

Publication type:

Article

Distribution, phenotype, functional and clinical relevance of CD8<sup>+</sup>CD103<sup>+</sup> tissue-resident memory T cells in human gastric cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1645, doi. 10.1007/s00262-021-03105-0

By:

Shen, Yang;
Li, Xiao-long;
Li, Yu-xian;
Shan, Zhi-guo;
Zhao, Yong-liang;
Cheng, Ping;
Zhao, Zhuo;
Zhang, Jin-yu;
Chen, Weisan;
Zhuang, Yuan;
Ma, Dai-yuan;
Zou, Quan-ming;
Qiu, Yuan;
Peng, Liu-sheng

Publication type:

Article

Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1777, doi. 10.1007/s00262-021-03104-1

By:

Bellone, Matteo;
Bregni, Marco;
Bronte, Vincenzo;
Ugel, Stefano;
Ferrucci, Pier Francesco;
Di Nicola, Massimo;
Nisticò, Paola;
Zuccolotto, Gaia;
Rosato, Antonio;
Russo, Vincenzo;
Sica, Antonio;
Colombo, Mario P.

Publication type:

Article

Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1633, doi. 10.1007/s00262-021-03103-2

By:

Xue, Jun-shuai;
Liu, Hui;
Meng, Guang-Xiao;
Ding, Zi-Niu;
Yan, Lun-Jie;
Yao, Sheng-Yu;
Li, Hai-Chao;
Dong, Zhao-Ru;
Chen, Zhi-Qiang;
Hong, Jian-Guo;
Li, Tao

Publication type:

Article

Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1771, doi. 10.1007/s00262-021-03101-4

By:

Page, Audrey;
Laurent, Emilie;
Nègre, Didier;
Costa, Caroline;
Pierre, Véronique;
Defrance, Thierry;
Cosset, François-Loïc;
Fusil, Floriane

Publication type:

Article

TGF-β orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1583, doi. 10.1007/s00262-021-03081-5

By:

Gneo, Luciana;
Rizkalla, Nagy;
Hejmadi, Rahul;
Mussai, Francis;
de Santo, Carmela;
Middleton, Gary

Publication type:

Article

Redirecting host preexisting influenza A virus immunity for cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1611, doi. 10.1007/s00262-021-03099-9

By:

Chaganty, Bharat K. R.;
Qiu, Songbo;
Lu, Yang;
Lopez-Berestein, Gabriel;
Ozpolat, Bulent;
Fan, Zhen

Publication type:

Article

Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1549, doi. 10.1007/s00262-021-03097-x

By:

Liu, Chuan;
Zhang, Guangwei;
Xiang, Kanghui;
Kim, Yohan;
Lavoie, Roxane R.;
Lucien, Fabrice;
Wen, Ti

Publication type:

Article

Identification of HLA-A2 restricted epitopes of glypican-3 and induction of CTL responses in HLA-A2 transgenic mice.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1569, doi. 10.1007/s00262-021-03096-y

By:

Jin, Xiaoxiao;
Liu, Xiaotao;
Zhou, Zining;
Ding, Yan;
Wu, Yandan;
Qiu, Jie;
Shen, Chuanlai

Publication type:

Article

Robust immune response stimulated by in situ injection of CpG/αOX40/cGAMP in αPD-1-resistant malignancy.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1597, doi. 10.1007/s00262-021-03095-z

By:

Cai, Luya;
Du, Xuedan;
Zhang, Cheng;
Yu, Shanshan;
Liu, Lixiao;
Zhao, Jinduo;
Zhao, Ye;
Zhang, Chunhong;
Wu, Jinting;
Wang, Bin;
Chen, Yingyu;
Su, Xiaoping;
Yan, Xiaojian;
Li, Wenfeng

Publication type:

Article

Treatment efficacy of HER2-mutant lung adenocarcinoma by immune checkpoint inhibitors: a multicenter retrospective study.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1625, doi. 10.1007/s00262-021-03100-5

By:

Chu, Xiangling;
Qiang, Huiping;
Xie, Mengqing;
Li, Xing;
Zhao, Jing;
Wu, Yan;
Zhou, Juan;
Ye, Jinyan;
Zhao, Chao;
Han, Chaonan;
Chu, Tianqing;
Su, Chunxia

Publication type:

Article

Endoplasmic reticulum stress-induced release and binding of calreticulin from human ovarian cancer cells.

Published in:

Cancer Immunology, Immunotherapy, 2022, v. 71, n. 7, p. 1655, doi. 10.1007/s00262-021-03072-6

By:

Abdullah, Trefa M.;
Whatmore, Jacqueline;
Bremer, Edwin;
Slibinskas, Rimantas;
Michalak, Marek;
Eggleton, Paul

Publication type:

Article